Cellectis SA(CLLS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CLLS Cellectis SA

Trading 04-22 12:41:52 EDT

3.94

-0.06

-1.50%

High4.00	Low3.90	Vol19.35K
Open4.00	D1 Closing4.00	Amplitude2.50%
Mkt Cap397.94M	Tradable Cap263.63M	Total Shares101.00M
T/O77.07K	T/O Rate0.03%	Tradable Shares66.91M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CLLS","market":"US","secType":"STK","nameCN":"Cellectis SA","latestPrice":3.94,"timestamp":1776875818145,"preClose":4,"halted":0,"volume":19352,"delay":0,"changeRate":-0.015000000000000013,"floatShares":66909900,"shares":101000000,"eps":-0.674047,"marketStatus":"Trading","change":-0.06,"latestTime":"04-22 12:41:52 EDT","open":4,"high":4,"low":3.9,"amount":77069.5393256,"amplitude":0.025,"askPrice":3.99,"askSize":970,"bidPrice":3.87,"bidSize":220,"shortable":3,"etf":0,"ttmEps":-0.674047,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1776888000000},"marketStatusCode":2,"adr":1,"adrRate":1,"listingDate":1427256000000,"exchange":"NASDAQ","adjPreClose":4,"preHourTrading":{"tag":"盘前","latestPrice":3.93,"preClose":4,"latestTime":"09:25 EDT","volume":4339,"amount":17042.6009724,"timestamp":1776864351442,"change":-0.07,"changeRate":-0.0175,"amplitude":0.0125},"postHourTrading":{"tag":"盘后","latestPrice":4,"preClose":4,"latestTime":"19:35 EDT","volume":37,"amount":147.7,"timestamp":1776814503604,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.109138,"impliedVol":0.2163,"impliedVolPercentile":0.0398},"requestUrl":"/m/hq/s/CLLS/wiki","defaultTab":"wiki","newsList":[{"id":"2628724604","title":"European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2628724604","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628724604?lang=en_us&edition=fundamental","pubTime":"2026-04-20 23:11","pubTimestamp":1776697897,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts started the week tracking lower late Monday morning, as the S&P Europe Select ADR Index was falling 0.54% to 1,830.11.From continenta","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4009","LU2543165471.USD","BK4007","SQNS","BPH","BTI.AU","BK4521","BDRX","LU1162221912.USD","BK4141","BK4207","LNOK","AKTX","AFG","SAN","BK4201","BK4132","LU0006061336.USD","LU0072461881.USD","BK4515","BK4075","BK7142","LU0320765646.SGD","BK4020","CUK","BTI","NOK","IE00BMPRXN33.USD","SAN.AU","BK4554","GRFS","NCNA","BK4142","BK4547","BK4591","BK4117","BK4532","BK4588","BP","ERIC","LU1829250122.USD","IE00BMPRXR70.SGD","VOD","BK7062","CLLS","LU0162691827.USD","OPRA","BBVA","WPP.AU","WPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627449692","title":"Cellectis Price Target Maintained With a $8.00/Share by Citizens","url":"https://stock-news.laohu8.com/highlight/detail?id=2627449692","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627449692?lang=en_us&edition=fundamental","pubTime":"2026-04-14 20:48","pubTimestamp":1776170880,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CLLS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 14, 2026 08:48 ET (12:48 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627834466","title":"Cellectis highlights Allogene ALPHA3 trial data, potential milestone payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2627834466","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627834466?lang=en_us&edition=fundamental","pubTime":"2026-04-14 04:45","pubTimestamp":1776113137,"startTime":"0","endTime":"0","summary":"Cellectis (CLLS) highlighted the interim futility analysis announced by Allogene Therapeutics (ALLO) from Allogene’s sponsored pivotal ALPHA3 trial...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cellectis-highlights-allogene-alpha3-trial-data-potential-milestone-payments-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cellectis-highlights-allogene-alpha3-trial-data-potential-milestone-payments-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CLLS","BK4505","ALLO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627465753","title":"Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2627465753","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627465753?lang=en_us&edition=fundamental","pubTime":"2026-04-14 04:30","pubTimestamp":1776112200,"startTime":"0","endTime":"0","summary":"NEW YORK, April  13, 2026 (GLOBE NEWSWIRE) -- Cellectis (or the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/13/3272912/0/en/Cema-Cel-Pivotal-Trial-Interim-Data-Highlight-Strength-of-Cellectis-Allogeneic-CAR-T-Platform.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","BK4022","LU0963586101.USD","CRS","IE00B66KJ199.SGD","BK4230","IE00B7SZL793.SGD","IE00B19Z4B17.USD","BK4139","CAR","IE0031619046.USD","LU2065731478.USD","BK4187","CLLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627451298","title":"European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2627451298","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627451298?lang=en_us&edition=fundamental","pubTime":"2026-04-13 23:04","pubTimestamp":1776092679,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts began the week little changed late Monday morning, edging 0.02% higher to 1,822.16 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Cellectis  and telecommunications company Nokia , which advanced 26% and 9.3%, respectively. They were followed by furniture maker Natuzzi   and biotech firm Evaxion , which climbed 7.1% and 3.4%, respectively.The decliners from continental Europe were led by accommodations booking company trivago  and brewing company Anheuser-Busch InBev , which dropped 3.3% and 1.2%, respectively. They were followed by pharmaceutical company Sanofi  and lender Banco Santander , which were off 0.9% and 0.8%, respectively.The gainers from the UK were led by pharmaceutical company Silence Therapeutics  and biopharmaceutical company Mereo BioPharma Group , which rose 7% and 4.8%, respectively. They were followed by biopharmaceutical companies NuCana","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4077","SLN","IE00BMPRXN33.USD","NOK","BK4547","BK4521","BK7142","SAN","BK4007","BK4139","BK4142","BK4095","BUD","TRVG","MREO","TRIB","LNOK","BK4158","BK4107","SAN.AU","IE00BMPRXR70.SGD","IE00BFXG1179.USD","BK4505","AFG","EVAX","SNY","BK4207","BK7119","BK4082","NTZ","BK4588","BUD.AU","BK4585","BCYC","BK4117","BDRX","CLLS","CUK","NCNA","BK4020","BCS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626010135","title":"European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2626010135","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626010135?lang=en_us&edition=fundamental","pubTime":"2026-04-09 23:14","pubTimestamp":1775747664,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking lower late Thursday morning, declining 0.48% to 1,803.06 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm Evaxion  and pharmaceutical company Ascendis Pharma , which advanced 4% and 3.1% respectively. They were followed by oil and gas company Eni  and telecommunications company Nokia , which increased 3% and 0.3% respectively.The decliners from continental Europe were led by biopharmaceutical company Grifols  and software firm SAP , which dropped 4.4% and 3.8% respectively. They were followed by internet browser company Opera  and biopharmaceutical company Cellectis , which lost 3% and 2.5% respectively.The gainers from the UK were led by biopharmaceutical company NuCana  and oil and gas company BP , which rose 5.5% and 2.2% respectively. They were followed by biotech firm Trinity Biotech  and biopharmaceutical company Amarin , which were up 1.8% and 0.5% res","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LNOK","PXJ","AFG","EVAX","ERX","TRIB","LU0072461881.USD","IE00BMPRXR70.SGD","BK4142","WPP","BK4547","BK4588","SAP","BK4139","SLN","E","BK4082","GUSH","BP","ASND","DIG","VDE","LU0162691827.USD","IXC","BK4020","USE","IEO","CLLS","NCNA","BPH","BK4009","GRFS","DBC","BDRX","DRIP","LU0889565916.HKD","DRLL","OPRA","BK4117","AMRN","BK4023","LU0320765646.SGD","BK4585","DBE","WPP.AU","CUK","NOK","BK4528","IE00BMPRXN33.USD","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625851954","title":"European Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2625851954","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625851954?lang=en_us&edition=fundamental","pubTime":"2026-04-07 23:11","pubTimestamp":1775574700,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending lower late Tuesday morning, as they were down 0.67% to 1,745.91 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by petroleum refiner Equinor  and 3D printer company Materialise , which advanced 1.6% and 1.2% respectively. They were followed by biopharmaceutical company argenx  and internet browser company Opera , which increased 0.5% and 0.4% respectively.The decliners from continental Europe were led by biotech firm BioNTech  and pharmaceutical company Ascendis Pharma , which dropped 3% each. They were followed by biopharmaceutical companies Grifols  and Cellectis , which lost 2.9% each.The gainers from the UK were led by communications company WPP  and telecommunications operator Vodafone Group , which rose 2.4% and 1.9% respectively. They were followed by educational publisher Pearson  and biopharmaceutical company NuCana , which were up 1.4% and 1.1% respectively.The de","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0109394709.USD","BK4111","GRFS","IE0034235188.USD","BDRX","BK4201","WPP.AU","IE00B4R5TH58.HKD","BK4535","OPRA","SLN","ASND","TRIB","BK4107","ARGX","IE0002141913.USD","BK4082","BK4204","EQNR","BK4568","IE00BFTCPJ56.SGD","BK4585","AFG","BK4142","LU1983260115.SGD","CLLS","CUK","BK4139","BK4132","BK4548","IE00B2B36J28.USD","PSO","VOD","BNTX","MTLS","NCNA","BK4023","BK4009","BK4532","IE00BJT1NW94.SGD","IE0009355771.USD","LU0320765992.SGD","WPP","LU0889565916.HKD","BK4505","BK4551","IE00BJJMRZ35.SGD","BK4117","BK4546","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625567741","title":"European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2625567741","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625567741?lang=en_us&edition=fundamental","pubTime":"2026-04-06 23:06","pubTimestamp":1775487989,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts started the week lower late Monday morning, declining 0.21% to 1,753.66 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by medical device maker EDAP TMS  and biopharmaceutical company Cellectis , which rose 5% and 2.6% respectively. They were followed by telecommunications company Nokia  and 3D printer company Materialise , which were up 1.5% and 1.1% respectively.The decliners from continental Europe were led by biopharmaceutical company DBV Technologies  and software firm SAP , which fell 1.7% and 1% respectively. They were followed by telecommunications company Ericsson  and semiconductor company Sequans Communications , which were off 0.4% and 0.2% respectively.The gainers from the UK were led by biopharmaceutical company Mereo BioPharma Group  and software company Endava , which advanced 3.7% and 1.2% respectively. They were followed by communications company WPP  and lender Lloyds ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4547","BHP.AU","LU0300736492.USD","BK4554","LU0648005311.SGD","BK7095","BK4107","MREO","BK4207","BK4588","BK4505","MTLS","BK4139","BK4023","LNOK","BK4515","SAP","BK4141","BDRX","BK4020","LU0300736062.USD","EDAP","SLN","BHP","BK4521","WPP.AU","BK4613","NOK","DAVA","CLLS","DAVA.AU","WPP","ERIC","BK4591","DBVT","BK4585","BK7507","LU0084288595.USD","IE00BMPRXR70.SGD","BK4082","AFG","BK4546","SQNS","LYG","BK7511","BK4168","BK4528","BK4009","BK4134","AKTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623953321","title":"European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2623953321","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623953321?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:22","pubTimestamp":1774970573,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking higher late Tuesday morning, rising 1.72% to 1,721.10 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical companies DBV Technologies  and Cellectis , which climbed 7.6% and 4.4% respectively. They were followed by pharmaceutical company Ascendis Pharma  and biopharmaceutical company Grifols , which advanced 3.9% and 3.6% respectively.The only decliners from continental Europe were biotech firm Evaxion  and consumer goods company Unilever , which fell 5.8% and 5.5% respectively.The gainers from the UK were led by biotech firm Autolus Therapeutics  and pharmaceutical company Silence Therapeutics , which rose 10% and 6% respectively. They were followed by biopharmaceutical companies Mereo BioPharma Group  and Bicycle Therapeutics , which were up 5.3% and 4.8% respectively.The decliners from the UK and Ireland were led by biotech firm Trinity Biotech  and bioph","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MREO","BK4007","AFG","BK4592","BK4588","BK4082","LU0124676726.USD","LU0889565916.HKD","UL","TRIB","BDRX","ULVR.UK","BK4585","BK4139","SNN","LU0320765992.SGD","BK4117","BK4183","EVAX","UN","AKTX","CLLS","BCYC","LU0109394709.USD","AUTL","BK4505","GRFS","ASND","SLN","LU0689626769.HKD","BK4107","DBVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623341038","title":"European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2623341038","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623341038?lang=en_us&edition=fundamental","pubTime":"2026-03-30 23:07","pubTimestamp":1774883261,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary kicked off the week higher late Monday morning, rising 0.78% to 1,700.55 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by petroleum refiner Equinor  and internet advertising firm Criteo , which rose 3.8% and 3.4%, respectively. They were followed by software firm SAP  and pharmaceutical company Novo Nordisk , which were up 1.4% each.The decliners from continental Europe were led by medical device maker EDAP TMS  and biopharmaceutical company Cellectis , which dropped 2.8% and 2.5%, respectively. They were followed by accommodations booking company trivago  and biotech firm BioNTech , which lost 1.8% and 0.4%, respectively.The gainers from the UK were led by pharmaceutical company AstraZeneca , which advanced by 2.9%. It was followed by pharmaceutical company Silence Therapeutics  and utilities company National Grid , which increased 2.4% and 2.3%, respectively.The decliners from the UK and Irel","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVO.AU","SLN","IE00BKVL7J92.USD","EDAP","NVOH","BK4077","LU2462157665.USD","BK4599","CLLS","LU0154236417.USD","LU0320765992.SGD","BK7104","LU0109394709.USD","BK4588","MREO","BNTX","BK4139","BK4009","BK4551","NVOX","IE00BFMHRM44.USD","BK4532","BK4528","BK4117","EQNR","LU2456880835.USD","SAP","BK4585","BK4505","NGG","LU0058720904.USD","WPP.AU","BK4613","IHG","AZN","AFG","BK4201","AMRN","BK4208","WPP","CRTO","IE00B3T34201.USD","TRVG","BK4023","BK4548","IE00BZ1G4Q59.USD","LU2417539215.USD","BK4007","BK4107"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2622616488","title":"European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2622616488","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622616488?lang=en_us&edition=fundamental","pubTime":"2026-03-26 23:01","pubTimestamp":1774537315,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were lower late Thursday morning, declining 0.56% to 1,718.19 on the S&P Europe Select ADR Index, which is still up 0.2% for the week","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SLN","NVO","BK4208","BK4521","BK4532","BK7142","SAN","BK4007","LU0154236417.USD","NVOX","BK4139","ING","LU1093756168.USD","BK4134","NVOH","BK7104","ING.AU","BK7141","LU0084288595.USD","NVO.AU","TRIB","EDAP","BK4107","LU1093756325.SGD","SAN.AU","BK4023","AFG","DAVA.AU","BK4207","BK4599","IE00BFMHRM44.USD","NGG","LU0648005311.SGD","BBVA","BK4082","DAVA","BK4588","CLLS","BK4585","BK4117","BDRX","IE00BZ1G4Q59.USD","CRTO","AKTX","BK4009","LYG","BK7505","IE00BKVL7J92.USD","BCS","OPRA"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2621187755","title":"Clear Street Reaffirms Their Buy Rating on Cellectis SA (CLLS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2621187755","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621187755?lang=en_us&edition=fundamental","pubTime":"2026-03-21 01:35","pubTimestamp":1774028114,"startTime":"0","endTime":"0","summary":"Clear Street analyst William Maughan maintained a Buy rating on Cellectis SA today and set a price target of $9.00. Maughan covers the Healthcare s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/clear-street-reaffirms-their-buy-rating-on-cellectis-sa-clls-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/clear-street-reaffirms-their-buy-rating-on-cellectis-sa-clls-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CLLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620207340","title":"Cellectis SA reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2620207340","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620207340?lang=en_us&edition=fundamental","pubTime":"2026-03-20 13:58","pubTimestamp":1773986318,"startTime":"0","endTime":"0","summary":"Cellectis SA reports results for the quarter ended December 31 - Earnings SummaryCellectis SA CLLS.OQ reported a quarterly adjusted loss of 26 cents per share for the quarter ended December 31, lower ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nL8N40807G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620779332","title":"Cellectis Reports Full Year 2025 Financial Results and Provides a Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2620779332","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620779332?lang=en_us&edition=fundamental","pubTime":"2026-03-20 07:21","pubTimestamp":1773962460,"startTime":"0","endTime":"0","summary":"Pivotal Phase 2 with lasme-cel in r/r B-ALL (BALLI-01 trial) ongoing Phase 1: 83% ORR at RP2D and 100% ORR in the target Phase 2 populationIn target Phase 2 population: 100% of patients became eligibl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/19/3259513/0/en/Cellectis-Reports-Full-Year-2025-Financial-Results-and-Provides-a-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0031619046.USD","ASH","BK4109","CLLS","CRS","BK4006","IE00B19Z4B17.USD","LU2065731478.USD","LU2463526074.USD","BK4097","OS","IE00B66KJ199.SGD","ORR","BK4187","BK4139","LU0963586101.USD","IE00B7SZL793.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620574972","title":"European Equities Traded in US as ADRs Fall in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2620574972","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620574972?lang=en_us&edition=fundamental","pubTime":"2026-03-18 23:04","pubTimestamp":1773846263,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts fell late Wednesday morning with the S&P Europe Select ADR Index dropping 0.9% to 1,734.7.From continental Europe, the gainers were led by biopharmaceutical company Cellectis  and petroleum refiner Equinor , which rose 4% and 1.5%, respectively. They were followed by lenders Banco Bilbao Vizcaya Argentaria  and ING , which were up 0.3% and 0.2%, respectively.The decliners from continental Europe were led by furniture maker Natuzzi  and biotech firm BioNTech , which fell 10% and 3.4%, respectively. They were followed by pharmaceutical company Novo Nordisk  and consumer goods company Unilever , which were down 3.2% and 3%, respectively.The gainers from the UK were led by biotech firm Trinity Biotech  and oil and gas company BP , which advanced 3.6% and 1.7%, respectively. They were followed by lender Barclays  and pharmaceutical company Silence Therapeutics , which increased 0.9% and 0.3%, respectively.The decliners from ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BPH","BK4095","IE00BZ1G4Q59.USD","NVOX","BK4207","BK4201","UN","TRIB","MREO","LU0072461881.USD","LU1093756168.USD","EQNR","BK7104","LU1829250122.USD","UL","BK4532","BK4521","ULVR.UK","BP","LU0154236417.USD","BK4599","ING","LU0124676726.USD","BK7141","SLN","NVO","BBVA","LU0689626769.HKD","AKTX","LU0162691827.USD","NVOH","BK4183","IE00BKVL7J92.USD","BNTX","NTZ","ING.AU","BK4568","BK4588","BK4082","BK4139","BK4551","BK4505","BCYC","AUTL","BCS","BK4585","CLLS","BK4007","BK4548","NVO.AU"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2620311922","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2620311922","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620311922?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:00","pubTimestamp":1773828000,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Accenture Plc A                                  2Q      2.85   6:39 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLY","GUTS","CLLS","ABVX","DRIO","GANX","GEMI","GIS","FUFU","CCL","ARCO","ABSI","ARX","CURV","CNM","BRAG","AEBI","MXCT","ETON","AVAH","CRIS","ECOR","ALVO","DRI","FBRX","BIOA","BRZE","EQPT","FIVE","AIR","CUK","BABA","BGSI","FDX","BZ","CDNL","DLO","ELDN","ACN","CELC","CNXC","GRWG","HNRG","CAL","DERM","EVTL","CING","BZAI","AVR"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2620247504","title":"Cellectis SA  expected to post a loss of 25 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2620247504","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620247504?lang=en_us&edition=fundamental","pubTime":"2026-03-17 23:02","pubTimestamp":1773759745,"startTime":"0","endTime":"0","summary":"Cellectis SA  expected to post a loss of25cents a share - Earnings Preview Cellectis SA CLLS.OQ, CLLS.O is expected to  show a fall in quarterly revenue when it reports  results on March 19 for the pe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nL8N4051LW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619645914","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2619645914","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619645914?lang=en_us&edition=fundamental","pubTime":"2026-03-16 18:00","pubTimestamp":1773655200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·KE Hldgs ADR                                    4Q       .11   6:00 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBUS","CAAP","CELC","CRIS","BZ","AEBI","CDNL","CANG","AVR","DERM","DCGO","ZTO","ETON","ACN","ESLT","DLO","FIVE","BIOA","AVAH","DOCU","ABEO","ASO","BRAG","CTMX","ASRT","ALVO","BEKE","BGSI","FDX","DLTR","ATAT","BALY","CAL","AGEN","CLLS","ANDG","DRIO","ECOR","ELDN","FLD","BDTX","ARCO","DRI","BTM","CSIQ","EVEX","EQPT","FLY","ARX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2619711926","title":"European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2619711926","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619711926?lang=en_us&edition=fundamental","pubTime":"2026-03-14 00:11","pubTimestamp":1773418305,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were lower late Friday morning, declining 0.29% to 1,721.83 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm Evaxion  and biopharmaceutical company Cellectis , which rose 8.3% and 7.8% respectively. They were followed by telecommunications Nokia  and medical device maker EDAP , which increased 3.6% and 2.9% respectively.The decliners from continental Europe were led by 3D printer company Materialise  and accommodations booking site trivago , which fell 2.2% and 2% respectively. They were followed by lender ING   biopharmaceutical company Grifols , which were down 1.8% and 1.7% respectively.The gainers from the UK and Ireland were led by biopharmaceutical company Mereo BioPharma Group  and cruise line operator Carnival , which advanced 3.2% and 1.1% respectively. They were followed by telecommunications operator Vodafone  and alcoholic beverage company Diageo , which were u","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LNOK","GRFS","BK4132","ING.AU","BK4588","BK4532","BK7505","BDRX","ING","BK4117","BK7095","BK4082","BK4139","BCYC","BK7511","DEO","MREO","CLLS","LU0300736062.USD","AFG","EDAP","BK4007","BK4169","BK4547","BK4020","BK7507","LU0300736492.USD","BK4168","AKTX","VOD","BHP.AU","NOK","BK4585","BK4559","IE00BMPRXN33.USD","BHP","MTLS","CUK","IE00BMPRXR70.SGD","BK4142","BK4207","BK7141","EVAX","BK4077","BK4107","BK4023","DGE.UK","TRVG","BK4505","BK4546"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619152009","title":"Cellectis to Report Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2619152009","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619152009?lang=en_us&edition=fundamental","pubTime":"2026-03-13 04:30","pubTimestamp":1773347400,"startTime":"0","endTime":"0","summary":"NEW YORK, March  12, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS, NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to dev","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/12/3255153/0/en/Cellectis-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-March-19-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cellectis.com","stockEarnings":[{"period":"1week","weight":-0.0385},{"period":"1month","weight":0.1976},{"period":"3month","weight":-0.0268},{"period":"6month","weight":0.1527},{"period":"1year","weight":1.8986},{"period":"ytd","weight":-0.1736}],"compareEarnings":[{"period":"1week","weight":0.0139},{"period":"1month","weight":0.0856},{"period":"3month","weight":0.0273},{"period":"6month","weight":0.0481},{"period":"1year","weight":0.3701},{"period":"ytd","weight":0.0325}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates. The company is developing ALLO-715 and ALLO-605 for the treatment of multiple myeloma; ALLO-501 to treat large B-cell lymphoma; ALLO-316, an allogeneic engineered CAR T-cell product targeting CD70; ALLO-819 to treat acute myeloid leukemia; ALLO-213 for the treatment of small cell lung cancer; and ALLO-182 to treat gastric and pancreatic cancer. It also develops UCART22 for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia; UCART123 to treat acute myeloid leukemia; UCART 20x22 for relapsed or refractory B-Cell non-hodgkin's lymphoma; and cema-cel to treat relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma. The company has strategic alliances with Allogene Therapeutics, Inc. and Les Laboratoires Servier; research collaboration and exclusive license agreement with Iovance Biotherapeutics, Inc.; and joint research and collaboration, and investment agreement with AstraZeneca Holdings B.V., as well as with AstraZeneca Ireland Limited. Cellectis S.A. was founded in 1999 and is headquartered in Paris, France.","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.025762},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.069977},{"month":3,"riseRate":0.545455,"avgChangeRate":-0.047671},{"month":4,"riseRate":0.416667,"avgChangeRate":0.047618},{"month":5,"riseRate":0.636364,"avgChangeRate":0.053843},{"month":6,"riseRate":0.272727,"avgChangeRate":-0.075756},{"month":7,"riseRate":0.363636,"avgChangeRate":0.040955},{"month":8,"riseRate":0.727273,"avgChangeRate":0.056431},{"month":9,"riseRate":0.181818,"avgChangeRate":-0.108663},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.048106},{"month":11,"riseRate":0.545455,"avgChangeRate":0.268959},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.008306}],"exchange":"NASDAQ","name":"Cellectis SA","nameEN":"Cellectis SA","securityTypeName":"DR","adrRate":"1:1"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cellectis SA(CLLS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Cellectis SA(CLLS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Cellectis SA,CLLS,Cellectis SA股票,Cellectis SA股票老虎,Cellectis SA股票老虎国际,Cellectis SA行情,Cellectis SA股票行情,Cellectis SA股价,Cellectis SA股市,Cellectis SA股票价格,Cellectis SA股票交易,Cellectis SA股票购买,Cellectis SA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cellectis SA(CLLS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Cellectis SA(CLLS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction